Butterfly Network, Inc.

Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company focused on handheld, whole-body ultrasound systems built on proprietary semiconductor chip technology. The company entered public markets in February 2021 through a merger with Longview Acquisition Corp., a SPAC sponsored by Glenview Capital Management. The transaction was one of the more prominent healthcare-technology SPAC deals of that vintage, reflecting strong investor interest in digital health and point-of-care imaging. Butterfly Network continues to trade on the NYSE under the BFLY ticker and most recently filed a Form 10-Q with the SEC on July 30, 2026. For complete filings, deal history, and analytics on BFLY and the broader de-SPAC universe, sign up for full data on SpacDesk.